Tower Research Capital (TRC)’s ARMO BioSciences, Inc. Common Stock ARMO Stock Holding History

Tower Research Capital (TRC)’s Portfolio ARMO Stock Details ARMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-2,079	Closed	-$78K	–	4400
2018 Q1	$78K	Buy	+2,079	New	+$87.4K	0.01%	1430

Tower Research Capital (TRC)'s ARMO Position: Q2 2018 in Review

Tower Research Capital (TRC) sold out of ARMO BioSciences, Inc. Common Stock (ARMO) in Q2 2018, closing a stake of 2,079 shares — an estimated $78K sold.

Tower Research Capital (TRC) first reported a position in ARMO in Q1 2018 and held it in 1 quarter. The position peaked at $78K in Q1 2018. 0 funds tracked by Wall St. Rank hold ARMO as of Q2 2018.

Tower Research Capital (TRC) reported no remaining ARMO BioSciences, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Tower Research Capital (TRC) sold 2,079 ARMO BioSciences, Inc. Common Stock shares in Q2 2018, an estimated $78K.
Tower Research Capital (TRC) first reported a position in ARMO BioSciences, Inc. Common Stock in Q1 2018 and held it in 1 quarter.
Tower Research Capital (TRC)'s ARMO BioSciences, Inc. Common Stock position peaked at $78K in Q1 2018.
0 funds tracked by Wall St. Rank held ARMO BioSciences, Inc. Common Stock as of Q2 2018.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2018, filed 15 Aug 2018.